Arcutis Biotherapeutics, Inc.
ARQT- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001787306
In the last 90 days, Arcutis Biotherapeutics, Inc. insiders filed 0 open-market purchases and 12 sales; 272 institutions reported holding it in 13F filings for Q2 2026, worth $3.45B in total; no superinvestor holds it.
13F holders, Q1 2026
Institutional positions in Arcutis Biotherapeutics, Inc. as of Mar 31, 2026. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 270
- −6 vs. Q4 2025
- Shares held
- 132.4M
- +11.0M (+9.1%) vs. Q4 2025
- Total value
- $3.12B
- −$402.7M (−11.4%) vs. Q4 2025
- New holders
- 41
- 104 more added
- Sold out
- 47
- 88 more reduced
7 institutions that held it in Q4 2025 haven't filed for Q1 2026 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q4 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ARQT on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 272 | $3.45B |
| Q1 2026 | 270 | $3.12B |
| Q4 2025 | 283 | $3.75B |
| Q3 2025 | 239 | $2.37B |
| Q2 2025 | 230 | $1.78B |
| Q1 2025 | 241 | $1.97B |
| Q4 2024 | 208 | $1.79B |
| Q3 2024 | 188 | $1.20B |
| Q2 2024 | 186 | $1.18B |
| Q1 2024 | 168 | $1.24B |
| Q4 2023 | 133 | $327.1M |
| Q3 2023 | 134 | $356.7M |
| Q2 2023 | 136 | $684.0M |
| Q1 2023 | 144 | $787.6M |
| Q4 2022 | 141 | $979.6M |
| Q3 2022 | 139 | $1.13B |
| Q2 2022 | 115 | $1.05B |
| Q1 2022 | 106 | $929.8M |
| Q4 2021 | 93 | $961.8M |
| Q3 2021 | 103 | $1.09B |
| Q2 2021 | 102 | $1.24B |
| Q1 2021 | 94 | $1.35B |
Institutions, Q1 2026
Shares, value and share of portfolio for each institution holding Arcutis Biotherapeutics, Inc.; share changes are against Q4 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Quest Partners LLC | 0 | $0 | 0.00% | −10,175−100.0% | Sold out |
| Mercer Global Advisors Inc | 0 | $0 | 0.00% | −8,785−100.0% | Sold out |
| Caxton Associates LLP | 0 | $0 | 0.00% | −8,718−100.0% | Sold out |
| Skopos Labs, Inc. | 0 | $0 | 0.00% | −8,382−100.0% | Sold out |
| Whalen Wealth Management Inc. | 0 | $0 | 0.00% | −8,013−100.0% | Sold out |
| Verition Fund Management LLC | 0 | $0 | 0.00% | −7,482−100.0% | Sold out |
| Amalgamated Bank | 0 | $0 | 0.00% | −3,458−100.0% | Sold out |
| Quarry LP | 0 | $0 | 0.00% | −1,200−100.0% | Sold out |
| Clear Street Markets LLC | 0 | $0 | 0.00% | −822−100.0% | Sold out |
| CoreCap Advisors, LLC | 0 | $0 | 0.00% | −500−100.0% | Sold out |
| Daiwa Securities Group Inc. | 0 | $0 | 0.00% | −358−100.0% | Sold out |
| Evelyn Partners Investment Management LLP | 0 | $0 | 0.00% | −270−100.0% | Sold out |
| HM Payson & Co | 0 | $0 | 0.00% | −135−100.0% | Sold out |
| Commonwealth Retirement Investments LLC | 0 | $0 | 0.00% | −100−100.0% | Sold out |
| Golden State Wealth Management, LLC | 0 | $0 | 0.00% | −59−100.0% | Sold out |
| SageView Advisory Group, LLC | 0 | $0 | 0.00% | −47−100.0% | Sold out |
| Clearstead Advisors, LLC | 0 | $0 | 0.00% | −20−100.0% | Sold out |
| Vanguard Group Inc | – | – | – | – | Not filed |
| Capitolis Liquid Global Markets LLC | – | – | – | – | Not filed |
| Norges Bank | – | – | – | – | Not filed |
| CIBC Private Wealth Group, LLC | – | – | – | – | Not filed |
| CIBC World Markets Corp | – | – | – | – | Not filed |
| Global Retirement Partners, LLC | – | – | – | – | Not filed |
| Comerica Bank | – | – | – | – | Not filed |